Viracta Therapeutics, Inc.(VIRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VIRX Viracta Therapeutics, Inc.

交易中 12-23 14:07:28 EST

0.2324

+0.0224

+10.67%

最高0.2515	最低0.2200	成交量41.15万
今开0.2200	昨收0.2100	日振幅15.00%
总市值923.66万	流通市值666.77万	总股本3,974万
成交额9.71万	换手率1.43%	流通股本2,869万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VIRX","market":"US","secType":"STK","nameCN":"Viracta Therapeutics, Inc.","latestPrice":0.2324,"timestamp":1734980843871,"preClose":0.21,"halted":0,"volume":411513,"delay":0,"floatShares":28690451,"shares":39744222,"eps":-1.102224,"marketStatus":"交易中","marketStatusCode":2,"change":0.0224,"latestTime":"12-23 14:07:28 EST","open":0.22,"high":0.2515,"low":0.22,"amount":97139.44607694,"amplitude":0.15,"askPrice":0.2409,"askSize":607,"bidPrice":0.2324,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-1.102224,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1127793600000,"adjPreClose":0.21,"preHourTrading":{"tag":"盘前","latestPrice":0.22,"preClose":0.21,"latestTime":"09:18 EST","volume":11978,"amount":2641.2660250599997,"timestamp":1734963492252},"postHourTrading":{"tag":"盘后","latestPrice":0.2274,"preClose":0.21,"latestTime":"19:59 EST","volume":30371,"amount":6663.5175,"timestamp":1734742787539},"volumeRatio":0.548995,"impliedVol":0.4137,"impliedVolPercentile":0.51},"requestUrl":"/m/hq/s/VIRX","defaultTab":"news","newsList":[{"id":"2492134475","title":"Viracta Therapeutics, Inc.盘中异动 大幅上涨5.84%报0.228美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492134475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492134475?lang=zh_cn&edition=full","pubTime":"2024-12-19 02:08","pubTimestamp":1734545301,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日02时08分，Viracta Therapeutics, Inc.股票出现异动，股价急速拉升5.84%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Polyrizon Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cognition Therapeutics, Inc.涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3032.80%、610.76%、337.13%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、118.27%、105.17%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121902082195ea5803&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121902082195ea5803&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIRX","LENZ","BK4139"],"gpt_icon":0},{"id":"2492966392","title":"Viracta Therapeutics, Inc.盘中异动 股价大跌5.71%报0.200美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492966392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492966392?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:47","pubTimestamp":1734446853,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时47分，Viracta Therapeutics, Inc.股票出现波动，股价快速下跌5.71%。截至发稿，该股报0.200美元/股，成交量19.182万股，换手率0.48%，振幅3.73%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722473395ea3288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722473395ea3288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VIRX"],"gpt_icon":0},{"id":"2491305777","title":"Viracta Therapeutics, Inc.盘中异动 股价大涨6.95%报0.203美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491305777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491305777?lang=zh_cn&edition=full","pubTime":"2024-12-14 01:43","pubTimestamp":1734111816,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时43分，Viracta Therapeutics, Inc.股票出现异动，股价快速上涨6.95%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Innate Pharma、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为99.33%、90.63%、42.82%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为76.48%、65.55%、51.81%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121401433695e97f76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121401433695e97f76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VIRX","LENZ"],"gpt_icon":0},{"id":"2490933334","title":"Viracta Therapeutics, Inc.盘中异动 快速下挫6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490933334","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490933334?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:46","pubTimestamp":1734014768,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时46分，Viracta Therapeutics, Inc.股票出现波动，股价大幅下跌6.03%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Palisade Bio, Inc.、Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Palisade Bio, Inc.、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为2720.06%、60.60%、52.93%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Palisade Bio, Inc.、Trevi Therapeutics, Inc.，振幅分别为55.45%、45.71%、32.53%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224608a1e95849&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224608a1e95849&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VIRX","BK4139"],"gpt_icon":0},{"id":"2490890790","title":"Viracta Therapeutics, Inc.盘中异动 下午盘快速上涨5.18%报0.179美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490890790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490890790?lang=zh_cn&edition=full","pubTime":"2024-12-12 04:28","pubTimestamp":1733948900,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日04时28分，Viracta Therapeutics, Inc.股票出现波动，股价大幅上涨5.18%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Candel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为458.54%、301.59%、135.35%，振幅较大的相关个股有Candel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为183.73%、149.24%、127.38%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212042820984b63ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212042820984b63ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2490433310","title":"Viracta Therapeutics, Inc.盘中异动 早盘大幅下跌5.34%报0.165美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490433310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490433310?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:30","pubTimestamp":1733841035,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时30分，Viracta Therapeutics, Inc.股票出现波动，股价大幅下跌5.34%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Chimerix, Inc.、Uniqure N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1639.34%、397.89%、81.56%，振幅较大的相关个股有Silexion Therapeutics Corp、Glycomimetics, Inc.、Quoin Pharmaceuticals Ltd，振幅分别为9.70%、8.97%、7.62%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022303695e8adea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022303695e8adea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VIRX"],"gpt_icon":0},{"id":"2490798377","title":"Viracta Therapeutics, Inc.盘中异动 早盘股价大跌6.60%报0.147美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490798377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490798377?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:32","pubTimestamp":1733754753,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时32分，Viracta Therapeutics, Inc.股票出现异动，股价大幅下挫6.60%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2158.98%、23.59%、19.08%，振幅较大的相关个股有Rapport Therapeutics, Inc.、Nkgen Biotech, Inc.、Newamsterdam Pharma Company N.V.，振幅分别为106.84%、104.58%、102.13%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223234984ac488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223234984ac488&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VIRX"],"gpt_icon":0},{"id":"2489234871","title":"Viracta Therapeutics, Inc.盘中异动 股价大跌6.41%报0.146美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489234871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489234871?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:10","pubTimestamp":1733497838,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时10分，Viracta Therapeutics, Inc.股票出现波动，股价大幅跳水6.41%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Adc Therapeutics Sa、Cervomed Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为48.83%、35.33%、23.69%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、Cyclerion Therapeutics, Inc.，振幅分别为27.68%、24.33%、19.74%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231038971c26da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231038971c26da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VIRX","BK4139"],"gpt_icon":0},{"id":"2489902450","title":"Viracta Therapeutics, Inc.盘中异动 大幅下挫7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489902450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489902450?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:32","pubTimestamp":1733409169,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时32分，Viracta Therapeutics, Inc.股票出现波动，股价大幅跳水7.84%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Protara Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1772.26%、243.27%、206.68%，振幅较大的相关个股有Protara Therapeutics, Inc.、Psyence Biomedical Ltd.、Biomx Inc.，振幅分别为36.44%、18.25%、10.98%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223249ab5ffdfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223249ab5ffdfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VIRX"],"gpt_icon":0},{"id":"2488484946","title":"Viracta Therapeutics, Inc.盘中异动 早盘股价大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488484946","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488484946?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:36","pubTimestamp":1733236565,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时36分，Viracta Therapeutics, Inc.股票出现异动，股价急速下挫5.96%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为130.43%、69.99%、55.30%，振幅较大的相关个股有Coherus Biosciences, Inc.、万春医药、Cabaletta Bio, Inc.，振幅分别为24.09%、14.79%、12.35%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223605abf2fad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223605abf2fad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VIRX","BK4139"],"gpt_icon":0},{"id":"2487568331","title":"Viracta Therapeutics, Inc.盘中异动 早盘快速下跌5.34%报0.140美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487568331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487568331?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:52","pubTimestamp":1732891948,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时52分，Viracta Therapeutics, Inc.股票出现异动，股价大幅下挫5.34%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Passage Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Silo Pharma, Inc.、Tc Biopharm  Plc、Applied Therapeutics, Inc.较为活跃，换手率分别为154.58%、20.86%、13.31%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为130.29%、41.50%、41.02%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922522898e4676a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922522898e4676a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VIRX","LENZ"],"gpt_icon":0},{"id":"2486878011","title":"Viracta Therapeutics, Inc.盘中异动 早盘大幅下挫5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486878011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486878011?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:38","pubTimestamp":1732718326,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时38分，Viracta Therapeutics, Inc.股票出现异动，股价大幅跳水5.89%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Cyclerion Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Os Therapies Incorporated涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为823.37%、32.56%、7.36%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Cyclerion Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为30.63%、22.02%、20.35%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223846971a8df2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223846971a8df2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VIRX"],"gpt_icon":0},{"id":"2486888430","title":"Viracta Therapeutics, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486888430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486888430?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:51","pubTimestamp":1732636299,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时51分，Viracta Therapeutics, Inc.股票出现波动，股价快速跳水5.16%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Poseida Therapeutics, Inc.、Protagenic Therapeutics, Inc.、Ventyx Biosciences, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为36.64%、23.54%、21.29%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、34.09%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623513998e44b62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623513998e44b62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VIRX"],"gpt_icon":0},{"id":"2486254038","title":"Viracta Therapeutics, Inc.盘中异动 股价大跌5.97%报0.151美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486254038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486254038?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545176,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Viracta Therapeutics, Inc.股票出现异动，股价急速下跌5.97%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Citius Pharmaceuticals, Inc.、Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为86.44%、59.99%、37.56%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223256a2548d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223256a2548d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VIRX","LENZ"],"gpt_icon":0},{"id":"2485290443","title":"Viracta Therapeutics, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485290443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485290443?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:56","pubTimestamp":1732301770,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时56分，Viracta Therapeutics, Inc.股票出现波动，股价大幅拉升5.13%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1891.79%、156.33%、98.35%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Virpax Pharmaceuticals, Inc.，振幅分别为82.83%、77.41%、72.75%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025610a24e8ae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025610a24e8ae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2484923516","title":"Viracta Therapeutics, Inc.盘中异动 早盘快速下跌6.00%报0.141美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484923516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484923516?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:32","pubTimestamp":1732026734,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时32分，Viracta Therapeutics, Inc.股票出现波动，股价大幅跳水6.00%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为622.66%、77.64%、63.58%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Invizyne Technologies Inc.、Tff Pharmaceuticals, Inc.，振幅分别为28.79%、23.08%、22.91%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223214abcf69f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223214abcf69f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VIRX"],"gpt_icon":0},{"id":"2484671191","title":"Viracta Therapeutics, Inc.盘中异动 快速跳水5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484671191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484671191?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:51","pubTimestamp":1731941489,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时51分，Viracta Therapeutics, Inc.股票出现波动，股价快速下挫5.96%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为546.81%、393.28%、290.52%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fate Therapeutics, Inc.，振幅分别为118.81%、71.83%、62.38%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225129abccb681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225129abccb681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VIRX"],"gpt_icon":0},{"id":"2483309890","title":"Viracta Therapeutics, Inc.2024财年第三财季实现净利润-10.55百万美元，同比增加16.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483309890?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Viracta Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-10.55百万美元，同比增加16.27%；其中营业收入为0.00美元，每股基本收益为-0.27美元。从资产负债表来看，Viracta Therapeutics, Inc.总负债28.58百万美元，其中短期债务16.91百万美元，资产负债比为0.77，流动比率为0.77。机构评级：截至2024年11月16日，当前有3家机构对Viracta Therapeutics, Inc.目标价做出预测，其中目标均价为2.83美元，其中最低目标价为2.00美元，最高目标价为3.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000320a23b89e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000320a23b89e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIRX","LENZ"],"gpt_icon":0},{"id":"2483835812","title":"Viracta Therapeutics, Inc.盘中异动 早盘快速下跌5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483835812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483835812?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:48","pubTimestamp":1731512912,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时48分，Viracta Therapeutics, Inc.股票出现波动，股价大幅下挫5.94%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为457.13%、264.87%、95.99%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Lexeo Therapeutics, Inc.，振幅分别为84.00%、46.01%、44.21%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113234832a23480be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113234832a23480be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIRX","LENZ","BK4139"],"gpt_icon":0},{"id":"2481600652","title":"Viracta Therapeutics Inc  预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600652","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481600652?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:22","pubTimestamp":1730902928,"startTime":"0","endTime":"0","summary":"Viracta Therapeutics Inc  预计每股亏损 24 美分 - 财报前瞻Viracta Therapeutics Inc VIRX.OQ VIRX.O预计在11月7日公布截至2024年9月30日的财报时，季度营收将没有变化(预计)。LSEG分析师对Viracta Therapeutics Inc的平均预期是每股亏损24美分。华尔街对 Viracta Therapeutics Inc 的 12 个月目标价中位数为 3.50 美元，高于其上一次收盘价 0.20 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD2I9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.viracta.com","stockEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.3825},{"period":"3month","weight":-0.0617},{"period":"6month","weight":-0.6641},{"period":"1year","weight":-0.567},{"period":"ytd","weight":-0.6316}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viracta Therapeutics, Inc.于1998年2月10日在特拉华州注册成立。其子公司主要位于南旧金山、加利福尼亚州。Viracta是一家精准肿瘤学公司，主要针对与病毒相关的恶性肿瘤。Viracta的专有研究药物Nanatinostat，目前正在与抗病毒药valganciclovir组合作为口服联合疗法在EBV阳性淋巴瘤的2期临床试验中进行评估。Viracta正在将这种可诱导的合成致死性方法应用于与EBV相关的恶性肿瘤，例如鼻咽癌，胃癌和病毒相关的癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.473684,"avgChangeRate":0.07126},{"month":2,"riseRate":0.631579,"avgChangeRate":0.143175},{"month":3,"riseRate":0.526316,"avgChangeRate":0.062681},{"month":4,"riseRate":0.526316,"avgChangeRate":-0.003931},{"month":5,"riseRate":0.315789,"avgChangeRate":-0.004094},{"month":6,"riseRate":0.315789,"avgChangeRate":-0.032856},{"month":7,"riseRate":0.473684,"avgChangeRate":-0.026326},{"month":8,"riseRate":0.368421,"avgChangeRate":-0.028499},{"month":9,"riseRate":0.210526,"avgChangeRate":-0.100414},{"month":10,"riseRate":0.3,"avgChangeRate":-0.12385},{"month":11,"riseRate":0.4,"avgChangeRate":-0.039976},{"month":12,"riseRate":0.35,"avgChangeRate":0.062562}],"exchange":"NASDAQ","name":"Viracta Therapeutics, Inc.","nameEN":"Viracta Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viracta Therapeutics, Inc.(VIRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viracta Therapeutics, Inc.(VIRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viracta Therapeutics, Inc.,VIRX,Viracta Therapeutics, Inc.股票,Viracta Therapeutics, Inc.股票老虎,Viracta Therapeutics, Inc.股票老虎国际,Viracta Therapeutics, Inc.行情,Viracta Therapeutics, Inc.股票行情,Viracta Therapeutics, Inc.股价,Viracta Therapeutics, Inc.股市,Viracta Therapeutics, Inc.股票价格,Viracta Therapeutics, Inc.股票交易,Viracta Therapeutics, Inc.股票购买,Viracta Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viracta Therapeutics, Inc.(VIRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viracta Therapeutics, Inc.(VIRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}